>
Organization
Eli Lilly & Company
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Eli Lilly & Company

... leave the network, with the two sides in a dispute over pricing. Eli Lilly – The drugmaker said study results did not confirm the clinical ...
... PR Newswire Eli Lilly and Company (NYSE: LLY)=400 ng/mL) hepatocellular carcinoma (HCC) were published online today inThe ...
... After patent expirations and other woes,Eli Lilly has been leaning on a stable of new drugs for growth. ...
... When Eli Lilly announced during the recent J.P. Morgan Healthcare Conference that it would ...
... safety signals identified and the safety profile was comparable between treatment arms. Lilly plans to present the ANNOUNCE data at an upcoming medical conference and ...
... Analytics Officer and Vice President of Biometrics and Advanced Analytics at Eli Lilly and Co. Dr. Kulkarni leads a division of nearly 600 people composed ...
... October to support its early-stage pipeline, including three NASH programs from Eli Lilly & Co. It aims to begin clinical trials this year. “Erin is ...
... announced the expansion of its existing non-exclusive perpetual license agreement with Eli Lilly and Company. The expanded rights will more broadly enable EIi Lilly to ...
... Catalyst announced today that Bank of America, Deutsche Post DHL Group, Eli Lilly and Company, and Schneider Electric will receive the prestigious2019 Catalyst Award for ...
... (sintilimab injection) is an innovative drug jointly developed by Innovent and Eli Lilly and Company in China. Tyvyt® (sintilimab injection) is a type of immunoglobulin ...
Subscribe now for full coverage on Eli Lilly & Company
Start My Free Trial